WAIVER AND AMENDMENT AGREEMENTWaiver and Amendment Agreement • May 14th, 2012 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
Contract Type FiledMay 14th, 2012 Company Industry JurisdictionThis WAIVER AND AMENDMENT AGREEMENT (this “Amendment”), by and between ARCA biopharma, Inc., a Delaware corporation (the “Company”), and Christopher D. Ozeroff (“Executive”) is effective as of March 30, 2012 (the “Effective Date”).
WAIVER AND AMENDMENT AGREEMENTWaiver and Amendment Agreement • May 14th, 2012 • ARCA Biopharma, Inc. • In vitro & in vivo diagnostic substances • Colorado
Contract Type FiledMay 14th, 2012 Company Industry JurisdictionThis WAIVER AND AMENDMENT AGREEMENT (this “Amendment”), by and between ARCA biopharma, Inc., a Delaware corporation (the “Company”), and Michael R. Bristow (“Executive”) is effective as of March 30, 2012 (the “Effective Date”).